Development and validation of a heart failure with preserved ejection fraction cohort using electronic medical records
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2261
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Development and validation of a heart failure with preserved ejection fraction cohort using electronic medical records ; volume:18 ; number:1 ; day:28 ; month:6 ; year:2018 ; pages:1-8 ; date:12.2018
BMC cardiovascular disorders ; 18, Heft 1 (28.6.2018), 1-8, 12.2018
- Creator
-
Patel, Yash R.
- Contributor
-
Robbins, Jeremy M.
Kurgansky, Katherine E.
Imran, Tasnim
Orkaby, Ariela R.
McLean, Robert R.
Ho, Yuk-Lam
Cho, Kelly
Michael Gaziano, J.
Djousse, Luc
Gagnon, David R.
Joseph, Jacob
SpringerLink (Online service)
- DOI
-
10.1186/s12872-018-0866-5
- URN
-
urn:nbn:de:101:1-2018082519193408925808
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patel, Yash R.
- Robbins, Jeremy M.
- Kurgansky, Katherine E.
- Imran, Tasnim
- Orkaby, Ariela R.
- McLean, Robert R.
- Ho, Yuk-Lam
- Cho, Kelly
- Michael Gaziano, J.
- Djousse, Luc
- Gagnon, David R.
- Joseph, Jacob
- SpringerLink (Online service)
Other Objects (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Evaluation of mouse models of heart failure with preserved ejection fraction